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Highlights 
• Globally, 985 million women are aged 50 and over, leading to increasing concerns about chronic diseases 
which can adversely affect quality of life and independent living.   
• Optimization of diet is increasingly being accepted as playing a role in the strategies to reduce the risk of 
chronic disease and to promote menopausal health. 
• Overall, both all-cause and cause-specific mortality are reduced by the Mediterranean diet, with the major 
benefits seen with cardiovascular disease.  
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Introduction: Globally, 985 million women are aged 50 and over, leading to increasing concerns about chronic 
conditions such as cardiovascular disease, osteoporosis, dementia, and cognitive decline, which can adversely affect 
quality of life and independent living.   
Aim: To evaluate the evidence from observational studies and randomized trials on the effects of the 
Mediterranean diet on short- and long-term menopausal health: estrogen deficiency symptoms, cardiovascular 
disease, osteoporosis, cognitive and mental health, breast cancer, and all-cause mortality.   
Materials and methods: Literature review and consensus of expert opinion. 
Summary recommendations:  The Mediterranean diet is a non-restrictive dietary pattern common in the olive-
growing areas of the Mediterranean basin. It may improve vasomotor symptoms, cardiovascular risk factors such as 
blood pressure, cholesterol and blood glucose levels, as well as mood and symptoms of depression. Long-term 
adherence may: improve cardiovascular risk and events, and death; improve bone mineral density; prevent 
cognitive decline; and reduce the risk of breast cancer and all-cause mortality.  
 




Women are living longer. The United Nations has estimated that, worldwide, 985 million women in 2020 are aged 50 
and over. The figure is expected to rise to 1.65 billion by 2050 [1].  Not surprisingly, the immediate and long-term 
sequelae of postmenopausal estrogen deficiency and aging present an enormous problem to healthcare systems. 
There are increasing concerns about non-communicable diseases (NCDs) such as cardiovascular disease (CVD), 
osteoporosis, dementia, and cognitive decline, which can adversely affect quality of life and independent living.  
 
The optimization of diet is increasingly being accepted as playing a role in the strategies to reduce the risk of NCDs 
and to promote women’s health at the menopause. The concept has been recognized worldwide [2]. The EAT-Lancet 
Commission [3, 4] has promoted the concept that a nutritionally optimal dietary pattern is compatible with the United 
Nations Sustainable Developmental Goals [5]. In addition to meeting age- and gender-related nutrient requirements, 
there has been increasing focus on the other health benefits of specific dietary patterns, such as the Mediterranean 
diet (MedDiet) [6].  
 
Growing international interest in the MedDiet has led to many large observational studies with follow-up extending 
over decades as well as randomized controlled trials (RCTs). These have found a causal link between the MedDiet and 
health outcomes [7,8,9]. Overall, both all-cause and cause-specific mortality are reduced by the MedDiet [10,11, 12]. 
Further, the MedDiet has been shown to be feasible in non-Mediterranean populations, with some health services 
implementing it within “usual care” for NCDs [6,13,14,15,16,17].  
 
This position statement considers evidence from observational studies and RCTs which examine the MedDiet and 
focuses on its role in women’s post-reproductive health.  It considers the effects of the MedDiet on short-term and 
long-term menopausal health: estrogen deficiency symptoms, cardiovascular disease, osteoporosis, cognitive and 
mental health, breast cancer and all-cause mortality.  
 
Composition of the Mediterranean diet 
The MedDiet is the dietary pattern prevailing in the olive-growing areas of the Mediterranean basin; it has been 
influenced by various civilizations over the centuries [18]. In classical Greece and then in the Roman Empire it was 
based on bread, olive oil, and wine [19]. The Arabs and the Turkish Empire introduced spices from the Orient, and the 
role of legumes, grains and nuts was reinforced. New components of the region’s diet came with the discovery of the 
Americas, which introduced a variety of foods, including tomatoes, chilies, and new varieties of legumes. The dietary 
pattern is plant-dominant, characterized by daily consumption of fruit, vegetables, breads, other forms of cereals, 
beans and seeds, with olive oil and nuts as the principal source of fat. Dairy products (principally cheese and yogurt), 
eggs and fish are also eaten. Fish consumption varies with distance to the sea. The MedDiet includes low to moderate 
wine intake with meals, and some meat, usually poultry (chicken), rabbit, lamb, or goat. The MedDiet is low in 
saturated fat as olive oil and nuts are the major source of fat [19]. In addition, an important feature of the diet is 
frugality, imposed by the scarcity of food during winter or during periods of austerity. Also, many of those who adopt 
the MedDiet are physically active.  As the MedDiet is not based on dietary restriction and reflects the usual dietary 
pattern of diverse cultures, adherence is often higher than to other diets, such as the Dietary Approaches to Stop 
Hypertension (DASH) diet [6]. 
 
The Mediterranean diet and menopausal symptoms 
A single cohort study has examined the effect of the MedDiet on vasomotor symptoms (VMS), such as hot flushes 
and night sweats, and there is a paucity of data on other estrogen-deficiency symptoms, such as those due to vulvo-
vaginal atrophy. A cohort of over 6,000 women who had passed through a natural menopause in Australia found that 
adherence to a MedDiet decreased the risk of experiencing VMS by 20% (OR: 0.80 [95%CI: 0.69-0.92] P<0.001) [20]. 
 
The Women’s Health Initiative (n=6,104 post-menopausal women with VMS) RCT delivered intensive education and 
counselling to achieve a dietary pattern with high plant intake similar to the MedDiet. In women with mild VMS, the 
plant-based diet increased the likelihood of elimination of VMS within 12 months by 14% (OR: 1.14 [95%CI: 1.01-1.28] 
P=0.04); however, there was no improvement for women with moderate to severe VMS [21, 22]. The Study of 
Women’s Health Across the Nation (SWAN) obtained negative results when looking at the effect of nutrients in 
general on VMS in pre- and peri-menopausal women [23], suggesting it is the broader dietary pattern rather than 
meeting nutrient requirements which affects VMS. 
 
The Mediterranean diet and cardiovascular disease 
Cardiovascular disease has traditionally been seen as more of a men’s problem [24]. However, CVD, including both 
coronary heart disease (CHD) and stroke, is the main cause of death in women worldwide. The World Health 
Organization estimated that, in 2015, CVD was responsible for 31% of all global deaths (17.7 million deaths) [25]. In 
Europe, CVD is responsible for 2.1 million deaths (49% of all deaths) in women annually [26]. Not surprisingly, the 
main research focus regarding the benefits of the MedDiet has been on CVD. The first study was the observational 
Seven Countries Study, initiated after low rates of CHD in Naples were noted in the early 1950s [8].  It investigated 
the association of the MedDiet with CHD and stroke [9] and was followed by numerous observational studies and 
RCTs internationally. The latter studies tended to be more sophisticated in adjusting for variables such as body weight 
which affect CVD risk.  
 
Observational studies 
The largest and longest observational studies which examine the MedDiet and CVD are shown in Table 1. All the 
studies found that adherence to the MedDiet reduced the incidence and mortality of CVD. Studies which examined 
outcomes according to sex reported stronger findings in women [27,28].  Furthermore, systematic reviews and meta-
analyses have found mean relative risks of CVD around 0.70 and 0.80 in comparisons of women following the MedDiet 
and those not [29,30,31,32,33,34].  
 
Synthesizing these findings, a recent meta-analysis of observational studies found that high adherence to the 




Table 1: Observational studies which examine the association between a Mediterranean dietary pattern and cardiovascular disease and all-cause mortality. 
Study Country Sample size Percent 
female 
Follow-up duration Effect of MedDiet in total sample Effect of MedDiet in women only 
Northern Manhattan Study 
(Gardener et al., 2011)[35] 





64 9 years Inverse association: 
- Composite outcome: Ischemic stroke, myocardial 
infarction, or CVD-death. 
- CVD-death 
No effect: Myocardial infarction, ischemic stroke. 
Not reported. 
European Prospective Investigation into 
Cancer (EPIC)-NL 
(Hoevenaar-Blom et al., 2012)[36] 
Netherlands  34,708 75 10-15 years Inverse association: 
- CVD-death 
- CVD 
- Myocardial infarction 
- Stroke 
No effect: angina pectoris, transient ischemic attach, peripheral arterial 
disease. 
Not reported. 
European Prospective Investigation into 
Cancer (EPIC)-Norfolk 
(Tong et al., 2016) [37] 
United Kingdom 23,902 Not reported. 12.2 years Inverse association: 
- CVD 
- CVD-death 
- Composite outcome: ischemic heart disease, all-cause 
mortality. 
Not reported. 
Swedish Mammography Cohort Study 
(Tektonidis et al., 2015) [38] 
Sweden 32,921 100 10.4 years Not applicable. Inverse association: 
- Myocardial infarction 
- Heart failure 
- Ischemic stroke 
No effect: haemorrhagic stroke 
Västerbotten Intervention Program (VIP) 
population study (Tognon et al 2012)[39] 
Sweden 77,151 51 10 years Inverse association: 
- All-cause mortality 
No effect: CVD 
Inverse association: 
- CVD  
Seguimiento Universidad de Navarra (SUN) 
cohort 
(Carlos S et al., 2018) [40] 
Spain 22,786 61 Since 1999 Inverse association: 




Women’s Health Initiative 
(Hirahatake et al., 2019) [41] 
United States of 
America 





(Trébuchet et al., 2019) [42] 




No effect: Myocardial infarction, acute coronary syndrome, stroke. 
Not reported. 
Greek European Investigation into Cancer 
and Nutrition cohort (EPIC) 
(Dilis et al 2012; Misirli et al 2012) [27, 28] 
Greece 23,929 58 15.8 years Inverse association: 
- CHD-death 
- Cerebrovascular disease 
- Cerebrovascular disease-death 
No effect: CHD 
Inverse association:  
- CHD-death  
- CHD  
- Cerebrovascular disease 
- Cerebrovascular disease-death 
Stronger associations than in men. 
Seven Countries Study 
(Menotti et al 2012) [43] 
Italy 1,139 0 5 years Inverse association: 
- CHD-death 
Not applicable. 
MONItoring trends and determinants of 
Cardiovascular disease (MONICA) 
population study 
Tognon et al 2013 [44] 
Denmark 1,849 51 11 years Inverse association: 
- CVD 
- Myocardial infarction 
- All-cause mortality 
No effect: Stoke 
Not reported. 
CHD, coronary heart disease; CVD, cardiovascular disease. 
Randomized controlled trials 
The study that has received the most interest has been the PREvención con Dieta MEDiterránea (PREDIMED) study 
[45]. A primary prevention RCT, PREDIMED examined whether the unrestricted-calorie MedDiet was superior to a 
low-fat diet for CVD protection in older men and postmenopausal women with CVD risk factors. The 7,447 
participants (57% women) were randomized to one of three arms, two of them consisting of the MedDiet, one 
supplemented with extra-virgin olive oil and the other with nuts, and the third consisting of a low-fat diet. Energy 
restriction was not advised, nor was physical activity promoted. The primary objective was to measure the rate of 
clinical CVD events such as myocardial infarction (MI) and stroke, and CVD death. The study was prematurely stopped 
after 4.8 years of follow-up due to the clear benefits observed in both the olive oil (HR: 0.69 [95%CI: 0.53-0.91]) and 
nut arms (HR: 0.72 [95%CI: 0.54-0.95]). Consequently, PREDIMED has become a landmark study because, for the first 
time, it observed a clear causal association between MedDiet and objective CVD outcomes. However, gender 
differences were not reported. 
The Lyon Heart Study was a secondary prevention RCT in men and women aged under 70 years who had experienced 
a first MI. It investigated whether a MedDiet enriched with alpha-linoleic acid reduced the rates of cardiac death and 
non-fatal acute MI [46]. After a mean follow-up of 27 months, the risk ratio for the two main endpoints combined 
was 0.27 (95%CI: 0.12-0.59) and overall mortality 0.30 (95%CI: 0.11-0.82) in the MedDiet group. Differences between 
women and men were not presented.  
 
The Mediet Project randomized trial, with a sample of postmenopausal women, examined the effects of providing 
MedDiet cooking lessons with the instruction to use these skills at home. After 1 year, participants in the intervention 
group had improved their cholesterol levels and quality of life compared with the controls [47].  
 
A 2019 Cochrane systematic review that analyzed data from 30 RCTs, in both sexes and all age groups, including the 
above-mentioned RCTs, concluded that the trial evidence on the effectiveness of the MedDiet in the risk reduction 
or management of CVD was still uncertain due to statistical heterogeneity [48,49]. On the other hand, recommending 
an eating style can help women make positive changes. The MedDiet is included in nutrition guidelines to promote 
health and decrease CVD burden [16,17,50].  
 
The Mediterranean diet and cardiovascular risk factors 
Blood pressure 
The effect of the MedDiet on blood pressure has been investigated in both healthy and hypertensive individuals. 
There is a consensus that the MedDiet does decrease blood pressure but that the size of the effect is small. 
Observational studies have shown reductions of 2-3 mmHg and 1-2 mmHg in mean systolic and diastolic blood 
pressure, respectively [51]. The Hellenic National Nutrition and Health Survey (2013- 2015, n=1040) found that stricter 
MedDiet adherence decreased the odds of being hypertensive by 36% [52]. Randomized trials have found similar 




Evidence from RCTs shows that the MedDiet is associated with beneficial, although small, lipid changes. A reduction 
of up to 0.2 mmol/L (7.7mg/dL) has been found for total cholesterol and low-density lipoprotein cholesterol but little 
or no effect on high-density lipoprotein cholesterol has been found [48]. 
 
The PREDIMED study has generated a number of sub-studies in which changes in lipoproteins have been investigated 
[56,57,58]. Most of them support shifts in lipoprotein subfractions to a less atherogenic pattern, but more evidence 
is required regarding the effect specifically for menopausal and postmenopausal women. The Mediet Project RCT 
(see above), which recruited postmenopausal women, found a trend towards improved cholesterol levels in the 
MedDiet intervention group, compared with controls; however, specific levels were not reported [47].  
 
Central obesity and fat distribution 
Central obesity is associated with chronic low-grade inflammation, and is a risk factor for cardiometabolic 
syndrome. It has been investigated as one of the outcomes of the MedDiet. The conclusions from some studies are 
unclear as some MedDiets were low in calorie as well.  Thus it is hard to assess whether any effects seen were the 
result of the foods included in the diet or the calorie restriction [see for example 59]. Analysis of intervention trials 
overall shows that the MedDiet prevents an increase in central obesity [60]. Changes in waist circumference range 
between 0.5 cm and 7 cm. In RCTs which recruited only women, waist circumference decreased by 5.2 - 6.5cm.   
Improvements in waist-hip ratio were also noted. A limited effect on waist circumference was observed in the 
unrestricted-calorie high-vegetable-fat MedDiet PREDIMED study [61]. Thus, the adjusted difference in 5-year 
changes in waist circumference was -0·466 cm (-1·109 to 0·176; p=0·154) in the MedDiet with olive oil group and -
0·923 cm (-1·604 to -0·241; p=0·008) in the MedDiet with nut group, compared with the control group. 
 
Two randomized studies have provided information about fat distribution. One, using magnetic resonance imaging, 
found that a Mediterranean/low-carbohydrate diet mobilized specific ectopic fat depots, decreasing intrahepatic, 
intrapericardial, and pancreatic fat deposition [62]. Another study with dual-energy X-ray absorptiometry (DXA) found 
a reduction in subcutaneous fat and waist circumference but not visceral adipose tissue or other body composition 
measures [63]. 
 
Type 2 diabetes mellitus and metabolic syndrome 
A cluster of risk factors for CVD and type 2 diabetes mellitus, which occur together more often than by chance alone, 
are known as the metabolic syndrome. The risk factors include raised blood pressure, dyslipidemia (raised 
triglycerides and low-density lipoprotein [LDL] cholesterol and lowered high-density lipoprotein [HDL] cholesterol), 
raised fasting glucose, and central obesity [64]. The effect of the MedDiet on metabolic syndrome has been widely 
examined in observational and intervention studies. 
 
A meta-analysis of observational studies concluded that adherence to the MedDiet in women is not significantly 
associated with a reduced risk of metabolic syndrome. However, the subgroup analysis of women was based only on 
two of the 14 included studies, and the finding for combined sexes showed a substantial reduction of 19% (RR: 81% 
[95%CI: 0.71-0.92]) [65]. Other meta-analyses, which included both epidemiological and intervention studies, came 
to a similar result for combined sexes, but did not explore the effect in women alone [66,67]. Two MedDiet RCTs 
which were conducted exclusively in postmenopausal women found significant improvements in HDL cholesterol, 
triglycerides, blood pressure, glucose, and insulin sensitivity [68,69].  
 
Meta-analyses of the effect of the MedDiet on metabolic syndrome found that fasting glucose levels were slightly 
reduced, by about 0.1-0.3 mmol/L (2-6 mg/dL) [66,67]. In a sample of postmenopausal women, it was reduced by 
0.4 mmol/L (7mg/dL) [68].  
 
A meta-analysis of prospective studies of dietary patterns and type 2 diabetes found that adherence to the MedDiet 
(RR comparing extreme quantiles: 0.87 [95%CI: 0.82-0.93]), as well as to the experimental interventions in the 
Dietary Approaches to Stop Hypertension (DASH) (RR: 0.81 [95%CI: 0.72-0.92]) and the Alternative Healthy Eating 
Index (AHEI) studies (RR: 0.79 [95%CI: 0.69-0.90]), were associated with significant risk reductions in the incidence 
of type 2 diabetes. [70]. The US Atherosclerosis Risk in Communities study prospective cohort without diabetes, 
cardiovascular disease, or cancer at baseline (n = 11,991, mean age 54 years at study entry, 56% female, 75% white) 
with a median follow-up of 22 years also found lower diabetes risk with the MedDiet. [71]. Furthermore, 
associations were stronger for black versus white participants and weaker for obese versus those with normal body 
mass index (BMI), but there was no difference in the effect according to sex.  
 
A systematic review of all meta-analyses and RCTs with electronic searches up to January 2015 concluded that the 
MedDiet was associated with better glycemic control and cardiovascular risk factors than control diets, including 
lower-fat diets, suggesting that it is suitable for the overall management of type 2 diabetes in both sexes [72]. A 
subsequent network meta-analysis of randomized trials found that the MedDiet produced beneficial improvements 
in glycemic control, weight loss, and cardiovascular risk factors in people with type 2 diabetes [73]. An RCT which 
included women (mean age 50 years) newly diagnosed with type 2 diabetes compared the MedDiet with a low-fat 
diet. Reductions in weight, glycated hemoglobin (HbA1c) and systolic blood pressure were significantly greater in the 
MedDiet group than in the low-fat group [74]. 
 
In summary, adherence to the MedDiet reduces the risk of developing type 2 diabetes and improves its course, both 
in peri- or postmenopausal women and in men. Although the effects are small, the MedDiet may be preferable to 
restrictive diets such as a low-fat diet. Further observational studies and RCTs in peri- and postmenopausal women 
are required to improve the quality of the evidence. 
 
 
The Mediterranean diet and osteoporosis  
As the burden of osteoporotic fracture in terms of both mortality and disability is increasing, not surprisingly the 
effect of nutrition on bone health has attracted considerable attention [75]. Adequate intakes of calcium and vitamin 
D are recommended in most osteoporosis guidelines [76] and there is growing interest on the role of protein intake 
in bone accrual during childhood and adolescence and skeletal preservation in the post reproductive years [77,78]. 
 
A post-hoc analysis of the Women’s Health Initiative observational study published in 2016 found that women scoring 
in the highest quintile of the MedDiet had a 20% lower risk of hip, but not total, fracture [79]. A meta-analysis 
published in 2017 of three prospective cohort studies, including the Women’s Health Initiative observational study 
[79], concluded that only observational evidence on the effect of the MedDiet on bone health was available and that 
there was lack of agreement in the findings for hip fracture [80]. 
 
Subsequently, a one-year randomized trial undertaken across five European centers with 1294 participants (mean ± 
SD age: 70.9 ±4.0 years; 46% women) of a Mediterranean-like dietary pattern and a vitamin D3 supplement (400 IU 
/d) found no effect on bone mineral density (BMD) (site-specific or whole-body) [81].  Osteoporotic fracture was not 
evaluated. Subgroup analysis of individuals with osteoporosis at baseline (site-specific BMD T-score ≤ -2.5 SDs) 
showed that the MedDiet  attenuated the expected decline in femoral neck bone mineral density (n = 24 and 30 in 
the MedDiet and control groups, respectively; P = 0.04) but had no effect on lumbar spine or whole-body parameters. 
The authors concluded that the intervention had no effect on BMD in the normal age-related range, but significantly 
reduced the rate of loss of bone at the femoral neck in individuals with osteoporosis. Thus, further research is needed 
regarding the MedDiet and skeletal health and osteoporotic fracture; however, the MedDiet may be considered an 
appropriate diet for women with osteoporosis but should not be used as the primary treatment strategy. 
 
The Mediterranean diet and cognitive and mental health 
In 2017 it was estimated that 792 million people lived with a mental health disorder. This is slightly more than one in 
10 people globally (10.7% overall, 9.3% of men and 11.9% of women) [82].  Research on the effects of the MedDiet on 
cognition and mood disorders is summarized below.   
 
Cognition 
Dementia has become a public health priority: in 2016, the global number of individuals living with dementia was 
43.8 million, having increased from 20.2 million in 1990. More women than men had dementia in 2016 (27.0 million 
vs 16.8 million), and dementia was the fifth leading cause of death globally, accounting for 2.4 million deaths [83]. 
The World Health Organization has recognized diet as an important factor in reducing the risk of cognitive decline 
and dementia (84). Several cohort studies have been undertaken. A 2014  meta-analysis with five eligible studies  
found that in  cognitively normal individuals, higher adherence to the MedDiet was associated with a reduced risk of 
mild cognitive impairment (HR: 0.73 [95%CI: 0.56-0.96]; P=0.02) and Alzheimer’s disease (HR: 0.64 [95%CI: 0.46-0.89]; 
P=0.007]) [85]. In a 2017 systematic review and meta-analysis of nine cohort studies with a total of 34,168 
participants, the pooled analysis showed that the highest MedDiet category score, compared with the lowest 
category, was inversely associated with the development of cognitive disorders, and the pooled RR was 0.79 (95%CI: 
0.70-0.90) [86]. Protective effects have been reported in subsequent cohort studies undertaken in Europe, the USA 
and China [87,88,89]. Furthermore, higher self-reported MedDiet adherence is associated with beneficial effects on 
cognitive and neuroimaging phenotypes associated with Alzheimer’s disease [90]. 
 
A prospective cohort study of 16,058 postmenopausal women found that long-term adherence to a MedDiet pattern 
was linearly associated with improved cognitive scores in adjusted models [91]. However, in a study of 2,504 peri- 
and postmenopausal women with CVD, which per se increases the risk of cognitive decline, greater short-term 
adherence to the MedDiet had no effect on cognition [92]. This aligns with other findings regarding diet and cognition. 
For instance, long-term adherence to a diet that includes frequent consumption of fish, such as the traditional 
MedDiet, is associated with improved cognition, but short-term interventions, whether dietary or supplemental, have 




Mood and depression 
The important effect of diet on mood is such that lifestyle and dietary changes are incorporated in psychiatric clinical 
practice guidelines [ see for example 94].  Systematic reviews and meta-analyses have found that adherence to the 
MedDiet reduces the risk of depression [ see for example 95,96,97,98,99,100].  However, the Whitehall II Study could 
not detect an effect of the MedDiet on the recurrence of depressive symptoms [101]. Nevertheless, the SUN study, 
which followed individuals free of depression at baseline, found that adherence to the MedDiet (comparison of the 
highest vs the lowest quartile) was associated with a 25% mean reduction in depression diagnoses at two-year follow-
up [102]. Furthermore, the Women’s Health Initiative Observational Study found that a diet with a high glycemic 
index was a risk factor for depression [103].   
 
A well-controlled RCT which recruited participants with major depressive disorder, mostly women in the early peri-
menopause, found that adherence to the MedDiet for 3 months significantly improved depressive symptoms as well 
as depression remission, with a number needed to treat of 4.1 (95%CI: 2.3-27.8) [104].  
 
 
The Mediterranean diet and breast cancer 
Reports on a possible association between the MedDiet and the risk of breast cancer have been contradictory [105]. 
The EPIC cohort study, drawing on populations across Europe, found an inverse association with the risk of breast 
cancer in postmenopausal women (HR: 0.93 [95%CI: 0.88-1.00]) [106]. The Swedish Women’s Lifestyle and Health 
cohort reported no association [107]. Whilst a Western-style dietary pattern was found to increase the risk of breast 
cancer, a case-control study found that high adherence to the MedDiet decreased the risk (OR: 0.56 [95%CI: 0.40-
0.79]) [108]. The PREDIMED randomized trial reported that after 4.8 years, the MedDiet supplemented with olive oil 
significantly decreased the risk of breast cancer by 69% (HR: 0.31 [95%CI: 0.23-0.77]), but no statistically significant 
effect was found for the MedDiet supplemented with nuts [109]. Furthermore, the Women’s Health Initiative Dietary 
Modification Randomized Trial found that adoption of a low-fat diet with increased vegetable, fruit, and grain intake 
may reduce the risk of death as a result of breast cancer in postmenopausal women [110]. Inverse associations have 
been reported between the MedDiet and breast cancer subtypes, including ER-/PR- tumors (HR: 0.80 [95%CI: 0.65-
0.99]) and triple-negative tumors (OR: 0.32 [95%CI: 0.15-0.66]) [106,108].  
The Mediterranean diet and all-cause mortality  
As shown in Table 1, the MedDiet has been found to be inversely associated with both CVD-related and all-cause 
mortality in both Mediterranean and non-Mediterranean populations [12,111]. Furthermore, a systematic review 
and meta-analysis in 2019 involving 29 prospective studies with 1,676,901 participants, 221,603 of whom died in 
the study period, found that the risk of all-cause mortality linearly decreased with increase in adherence to a 
MedDiet [10].    
 
Summary 
The MedDiet is a non-restrictive dietary pattern which has proved broadly acceptable to non-Mediterranean as well 
as Mediterranean populations. While there is not one exact MedDiet, the defining characteristics include: high intake 
of olive oil, nuts, vegetables, fruits, and cereals; moderate intake of fish and poultry; low intake of dairy products, red 
meat, processed meats, and sweets; and wine in moderation, consumed with meals.  
 
In peri- and post-menopausal women, long-term high adherence may: 
• reduce cardiovascular risk, and the incidence of cardiovascular events and death 
• maintain bone mineral density whilst leading to more favorable body composition 
• improve bone mineral density in women with osteoporosis 
• help to prevent cognitive decline 
• reduce the risk of breast cancer 
• reduce the risk of all-cause mortality. 
 
In peri- and post-menopausal women, short-term high adherence may: 
• improve vasomotor symptoms 
• improve cardiovascular risk factors such as blood pressure, cholesterol, and blood glucose levels 
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